Centre for Addiction and Mental Health: clinical-trial pipeline

Centre for Addiction and Mental Health is the sponsor of 339 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 70 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials70
Phase 2/3 and 33
Countries4
New in 90 days2

Trials by phase

PhaseTrials
Not applicable263
Phase 229
Phase 427
Phase 111
Early phase 13
Phase 1/23
Phase 2/32
Phase 31

Trials by status

StatusTrials
Completed233
Recruiting45
Active, not recruiting21
Terminated16
Unknown10
Withdrawn or not authorised10
Not yet recruiting4

Condition areas

AreaTrials
Psychiatry and mental health212
Neurology13
Metabolic and endocrine (diabetes, obesity)12
Rare and genetic diseases4
Infectious disease and vaccines3
Cardiovascular2
Dermatology2
Women's health and obstetrics2
Gastroenterology and liver1
Nephrology and urology1
Oncology1

Countries

CountryTrials
Canada332
United States5
Finland1
India1

Latest changes

DayChangeTrial
2026-10-20New trial postedRemote Digital Assessments for Cognitive Disorders
2026-10-08New trial postedAddiction Psychoeducation for Canadian Muslims

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT06534047Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation TrialPhase 4RecruitingCanada
NCT06373484Matching Assessment and Treatment for Children With Disruptive Behaviour and Their ParentsNot applicableRecruitingCanada
NCT07274475Smoking Harm Reduction Using E-cigarettes and CytisineNot applicableNot yet recruiting
NCT06672588Magnetic Seizure Therapy for Schizophrenia - TrialNot applicableRecruitingCanada
NCT05142683Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled TrialNot applicableRecruitingCanada
NCT03672201Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in DementiaNot applicableActive, not recruitingCanada
NCT07033780Theta-Burst Stimulation to Treat DepressionPhase 1RecruitingCanada
NCT06512389Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use DisorderPhase 2Active, not recruitingCanada
NCT07783633Identifying Biomarkers of Response to Digital Interventions for Mood DisordersNot applicableRecruitingCanada
NCT06732128Nature-based Virtual Reality Intervention for Depression in Alzheimer's DiseaseNot applicableRecruitingCanada
NCT05859347Repetitive Transcranial Magnetic Stimulation for Cannabis Use DisorderNot applicableRecruitingCanada
NCT04972136rTMS for Depression in Young Adults With AutismNot applicableRecruitingCanada
NCT05531604Appetitive Conditioning in Anorexia NervosaNot applicableActive, not recruitingCanada
NCT07001735Talking for Change: Secondary Prevention of Child Sexual Abuse PerpetrationNot applicableRecruitingCanada
NCT05748990Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in SchizophreniaNot applicableActive, not recruitingCanada
NCT07405606Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use DisorderPhase 2Not yet recruitingCanada
NCT05142735Effects of NAC on Symptoms of CHR PatientsNot applicableRecruitingCanada
NCT06278246Investigating the Muscarinic System in Schizophrenia Using Positron Emission TomographyNot applicableActive, not recruitingCanada
NCT06798324tDCS Plus Varenicline for Smoking CessationPhase 4RecruitingCanada
NCT04325958Age Differences in the Effects of Cannabis on Simulated DrivingNot applicableRecruitingCanada
NCT03414151Gut Microbiome in AP NaiveNot applicableActive, not recruitingCanada
NCT06928935Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for PsychosisNot applicableRecruitingCanada
NCT02386670Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)Not applicableActive, not recruitingCanada
NCT06675461Brief Psychological Intervention for Suicidal Patients With Borderline Personality Disorder in the Emergency…Not applicableRecruitingCanada
NCT06783283TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI)Not applicableRecruitingCanada

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "Centre for Addiction and Mental Health clinical trials: 70 open, 3 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/centre-for-addiction-and-mental-health/, data as of 2026-10-25.